Piramal Enterprises lists potential investment areas4 min read . Updated: 03 Mar 2014, 07:51 PM IST
Chairman Ajay Piramal says Piramal Enterprises should have a turnover of at least `20,000 crore in next six years
Mumbai: Ajay Piramal-led pharma-to-financial services group Piramal Enterprises Ltd, which formed a core strategy team to identify potential investment opportunities after completing the sale of its drug formulation unit in 2012 to Abbott Laboratories for 17,000 crore, is ready with a list of businesses it wants to enter.
Login to enjoy exclusive benefits!
- Unlocked premium articles
- Personalized news
- Market Watchlist
- Insightful Newsletters & more